Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Juan David Assaf Pastrana"'
Autor:
Alberto Hernando-Calvo, Oriol Mirallas, David Marmolejo, Omar Saavedra, María Vieito, Juan David Assaf Pastrana, Susana Aguilar, Coro Bescós, Juan Lorente, Jordi Giralt, Sergi Benavente, Jordi Temprana-Salvador, Margarita Alberola, Rodrigo Dienstmann, Elena Garralda, Enriqueta Felip, Guillermo Villacampa, Irene Brana
Publikováno v:
Oral Oncology. 140:106364
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ad291c515e076ae474e80fabf9a48cec
https://doi.org/10.1016/j.oraloncology.2023.106364
https://doi.org/10.1016/j.oraloncology.2023.106364
Autor:
Susana Cedres Perez, Garazi Serna, Juan David Assaf Pastrana, Patricia Iranzo, Ana Callejo, Nuria Pardo, Alejandro Navarro, Alex Martinez-Marti, Carlos Cabrera Galvez, Alberto Gonzalez-Medina, Roberta Fasani, Xavier Guardia, Javier Gonzalo, Caterina Carbonell, Joan Frigola, Ramon Amat, Ana Vivancos, Paolo Nuciforo, Enriqueta Felip
Publikováno v:
Journal of Clinical Oncology. 40:e20595-e20595
e20595 Background: MPM is an aggressive cancer associated with asbestos exposure. Chemotherapy has been a mainstay of therapy and recently immunotherapy has been associated with survival improvements. Chemotherapy and immunotherapy influence the tumo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::87a18a3cc3594b01983eff28a6e2112f
https://doi.org/10.1200/jco.2022.40.16_suppl.e20595
https://doi.org/10.1200/jco.2022.40.16_suppl.e20595
Autor:
David Humberto Marmolejo Castañeda, Alex Martinez-Marti, Caterina Carbonell, Juan David Assaf Pastrana, Julia Lostes, A. Pedrola, Ramon Amat, N. Pardo, Susana Cedres Perez, Javier Gonzalo, A. Callejo, Rodrigo Dienstmann, Alejandro Navarro, Enriqueta Felip, P. Iranzo, Joan Frigola
Publikováno v:
Journal of Clinical Oncology. 39:e20563-e20563
e20563 Background: MPM is a highly aggressive pleural tumor associated with asbestos exposure and with limited survival despite systemic therapy. Histology is a prognostic factor and recently CheckMate 743 trial demonstrated survival benefit of immun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::41a68e99c85f5bd4f08aa18517f53962
https://doi.org/10.1200/jco.2021.39.15_suppl.e20563
https://doi.org/10.1200/jco.2021.39.15_suppl.e20563
Autor:
A. Pedrola, Ana Vivancos, Daniel Acosta, Teresa Macarulla Mercade, Juan David Assaf Pastrana, Helena Verdaguer, J. M. Pinto, Maria Teresa Salcedo, Jorge Hernando-Cubero, Rodrigo Dienstmann
Publikováno v:
Journal of Clinical Oncology. 37:4119-4119
4119 Background: AVC is a rare type of cancer with dismal prognosis and limited therapeutic options due to the lack of specific clinical trials. Two histologic subtypes predominate, namely pancreatobiliary and intestinal. A variety of molecular alter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::338d6b8bca492e4e6b5fb231c3bea11e
https://doi.org/10.1200/jco.2019.37.15_suppl.4119
https://doi.org/10.1200/jco.2019.37.15_suppl.4119